Integrative Genomics Analysis Reveals Silencing of β-Adrenergic Signaling by Polycomb in Prostate Cancer
Jindan Yu(Northwestern University), Arul M. Chinnaiyan(University of Michigan), Qi Cao(Northwestern University), Chad J. Creighton(Baylor College of Medicine), Rajal B. Shah(University of Michigan–Ann Arbor), Scott A. Tomlins(Stratasys (Israel)), Sooryanarayana Varambally(University of Alabama at Birmingham), David S. Morris(University of Michigan), Saravana M. Dhanasekaran(University of Michigan), Debashis Ghosh(Colorado School of Public Health), Jianjun Yu(Novartis (United States)), Víctor E. Márquez(Hospital la Serena), Ronglai Shen(Memorial Sloan Kettering Cancer Center), Guoan Chen(Nanchang University), Rohit Mehra(University of Michigan), Bharathi Laxman(University of Illinois Chicago)
Cited by 226
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k